PT3870574T - Derivados de aminopirimidina/pirazina como inibidores de ctps1 - Google Patents
Derivados de aminopirimidina/pirazina como inibidores de ctps1Info
- Publication number
- PT3870574T PT3870574T PT197899974T PT19789997T PT3870574T PT 3870574 T PT3870574 T PT 3870574T PT 197899974 T PT197899974 T PT 197899974T PT 19789997 T PT19789997 T PT 19789997T PT 3870574 T PT3870574 T PT 3870574T
- Authority
- PT
- Portugal
- Prior art keywords
- aminopyrimidine
- pyrazine derivatives
- ctps1 inhibitors
- ctps1
- inhibitors
- Prior art date
Links
- 150000005005 aminopyrimidines Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003216 pyrazines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18202136 | 2018-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3870574T true PT3870574T (pt) | 2023-03-16 |
Family
ID=63965420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT197899974T PT3870574T (pt) | 2018-10-23 | 2019-10-23 | Derivados de aminopirimidina/pirazina como inibidores de ctps1 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US11987573B2 (pl) |
| EP (1) | EP3870574B1 (pl) |
| JP (1) | JP7308263B2 (pl) |
| CN (1) | CN112839938B (pl) |
| AU (1) | AU2019367191B2 (pl) |
| BR (1) | BR112021005986A2 (pl) |
| CA (1) | CA3115568C (pl) |
| CR (1) | CR20210265A (pl) |
| DK (1) | DK3870574T3 (pl) |
| EA (1) | EA202191104A1 (pl) |
| ES (1) | ES2941981T3 (pl) |
| FI (1) | FI3870574T3 (pl) |
| HR (1) | HRP20230328T1 (pl) |
| HU (1) | HUE061652T2 (pl) |
| IL (1) | IL282386B2 (pl) |
| LT (1) | LT3870574T (pl) |
| MX (1) | MX2021004659A (pl) |
| PL (1) | PL3870574T3 (pl) |
| PT (1) | PT3870574T (pl) |
| RS (1) | RS64081B1 (pl) |
| SG (1) | SG11202103823PA (pl) |
| SI (1) | SI3870574T1 (pl) |
| WO (1) | WO2020083975A1 (pl) |
| ZA (1) | ZA202101788B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11505547B2 (en) | 2017-11-30 | 2022-11-22 | Step Pharma S.A.S. | Compounds |
| WO2019106156A1 (en) | 2017-11-30 | 2019-06-06 | Step Pharma S.A.S. | Compounds |
| EP3980410A1 (en) | 2019-06-04 | 2022-04-13 | Step Pharma S.A.S. | N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human ctps1 inhibitors for the treatment of proliferative diseases |
| US20220324837A1 (en) * | 2019-06-04 | 2022-10-13 | Step Pharma S.A.S. | N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases |
| WO2021053403A1 (en) | 2019-09-20 | 2021-03-25 | Step Pharma S.A.S. | Sulfonamide inhibitors as ctps1 inhibitors |
| WO2021053402A2 (en) | 2019-09-20 | 2021-03-25 | Step Pharma S.A.S. | Compounds |
| WO2023166078A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination treatments comprising a ctps1 inhibitor and a chek1 inhibitor |
| WO2023166077A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination of a ctps1 inhibitor and a atr inhibitor in cancer therapy |
| WO2023166080A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination treatments comprising a ctps1 inhibitor and a wee1 inhibitor |
| WO2023166076A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combinations of ctps1 and bcl2 inhibitors for cancer |
| WO2024133721A1 (en) | 2022-12-21 | 2024-06-27 | Step Pharma S.A.S. | Combinations of ctps1 inhibitor with iap inhibitor for use in the treatment of cancer |
| WO2024133730A1 (en) | 2022-12-21 | 2024-06-27 | Step Pharma S.A.S. | Ctps1 inhibitors for use in the treatment of ctps2 deficient cancer |
| CN118359588A (zh) * | 2023-01-19 | 2024-07-19 | 杭州英创医药科技有限公司 | 作为ctps1抑制剂的化合物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1575803A (en) | 1976-03-09 | 1980-10-01 | Fujisawa Pharmaceutical Co | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
| GB1555007A (en) | 1976-05-25 | 1979-11-07 | Fujisawa Pharmaceutical Co | Intermediates in the preparation of substituted cepham carboxylic acid derivatives and the preparation thereof |
| MXPA03001535A (es) | 2000-08-21 | 2004-12-13 | Pacific Corp | Derivados de tiourea novedosos y las composiciones farmaceuticas que contienen los mismos. |
| BR0114082A (pt) | 2000-09-25 | 2003-07-22 | Actelion Pharmaceuticals Ltd | Compostos, composições farmacêuticas, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas |
| US20030158218A1 (en) | 2001-12-21 | 2003-08-21 | Nantermet Philippe G. | Thrombin inhibitors |
| SI1771421T1 (sl) | 2004-07-26 | 2009-10-31 | Merck Serono Sa | Derivati n-hidroksiamida in njihova uporaba |
| EP1659113A1 (en) * | 2004-11-08 | 2006-05-24 | Evotec AG | Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
| PE20080839A1 (es) | 2006-09-11 | 2008-08-23 | Cgi Pharmaceuticals Inc | Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas |
| JP2011506445A (ja) * | 2007-12-13 | 2011-03-03 | アムジエン・インコーポレーテツド | γ−セクレターゼ調節剤 |
| KR101097312B1 (ko) | 2009-08-10 | 2011-12-23 | 삼성모바일디스플레이주식회사 | 유기 발광 소자 |
| ES2607635T3 (es) | 2012-12-13 | 2017-04-03 | F. Hoffmann-La Roche Ag | Derivados tiazol como inhibidores de tirosina quinasa de Bruton |
| JP2016028795A (ja) | 2013-03-28 | 2016-03-03 | 国立研究開発法人科学技術振興機構 | 触媒金属ナノ粒子含有複合体及びその利用 |
| CN105473136A (zh) * | 2013-04-18 | 2016-04-06 | 国家健康与医学研究院 | 用于在有此需要的受试者中抑制淋巴细胞增殖的方法和药物组合物 |
| WO2014186435A2 (en) * | 2013-05-14 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Compositions and methods for reducing neointima formation |
| GB201322333D0 (en) | 2013-12-17 | 2014-01-29 | Agency Science Tech & Res | WNT pathway modulators |
| CN104262071A (zh) | 2014-10-16 | 2015-01-07 | 中国科学院山西煤炭化学研究所 | 一种联苯类化合物的光催化合成方法 |
| US11505547B2 (en) | 2017-11-30 | 2022-11-22 | Step Pharma S.A.S. | Compounds |
| WO2019106156A1 (en) | 2017-11-30 | 2019-06-06 | Step Pharma S.A.S. | Compounds |
| WO2019179652A1 (en) | 2018-03-23 | 2019-09-26 | Step Pharma S.A.S. | Aminopyrimidine derivatives as ctps1 inhibitors |
| WO2019180244A1 (en) | 2018-03-23 | 2019-09-26 | Step Pharma S.A.S. | Aminopyrimidine derivatives as ctps1 inhibitors |
| US20230192673A1 (en) * | 2018-06-04 | 2023-06-22 | Step Pharma S.A.S. | Compounds |
| TW202233612A (zh) | 2020-10-23 | 2022-09-01 | 美商林伯士科羅索公司 | Ctps1抑制劑及其用途 |
-
2019
- 2019-10-23 MX MX2021004659A patent/MX2021004659A/es unknown
- 2019-10-23 EP EP19789997.4A patent/EP3870574B1/en active Active
- 2019-10-23 US US17/287,137 patent/US11987573B2/en active Active
- 2019-10-23 IL IL282386A patent/IL282386B2/en unknown
- 2019-10-23 SI SI201930504T patent/SI3870574T1/sl unknown
- 2019-10-23 JP JP2021522085A patent/JP7308263B2/ja active Active
- 2019-10-23 LT LTEPPCT/EP2019/078848T patent/LT3870574T/lt unknown
- 2019-10-23 CN CN201980063914.3A patent/CN112839938B/zh active Active
- 2019-10-23 SG SG11202103823PA patent/SG11202103823PA/en unknown
- 2019-10-23 CR CR20210265A patent/CR20210265A/es unknown
- 2019-10-23 BR BR112021005986-5A patent/BR112021005986A2/pt unknown
- 2019-10-23 ES ES19789997T patent/ES2941981T3/es active Active
- 2019-10-23 PL PL19789997.4T patent/PL3870574T3/pl unknown
- 2019-10-23 PT PT197899974T patent/PT3870574T/pt unknown
- 2019-10-23 HR HRP20230328TT patent/HRP20230328T1/hr unknown
- 2019-10-23 HU HUE19789997A patent/HUE061652T2/hu unknown
- 2019-10-23 AU AU2019367191A patent/AU2019367191B2/en active Active
- 2019-10-23 RS RS20230239A patent/RS64081B1/sr unknown
- 2019-10-23 WO PCT/EP2019/078848 patent/WO2020083975A1/en unknown
- 2019-10-23 FI FIEP19789997.4T patent/FI3870574T3/fi active
- 2019-10-23 DK DK19789997.4T patent/DK3870574T3/da active
- 2019-10-23 EA EA202191104A patent/EA202191104A1/ru unknown
- 2019-10-23 CA CA3115568A patent/CA3115568C/en active Active
-
2021
- 2021-03-17 ZA ZA2021/01788A patent/ZA202101788B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3870574A1 (en) | 2021-09-01 |
| CA3115568C (en) | 2023-07-11 |
| RS64081B1 (sr) | 2023-04-28 |
| EP3870574B1 (en) | 2023-01-04 |
| SI3870574T1 (sl) | 2023-05-31 |
| LT3870574T (lt) | 2023-04-11 |
| EA202191104A1 (ru) | 2021-07-19 |
| JP7308263B2 (ja) | 2023-07-13 |
| AU2019367191A1 (en) | 2021-04-29 |
| US20210387965A1 (en) | 2021-12-16 |
| ES2941981T3 (es) | 2023-05-29 |
| MX2021004659A (es) | 2021-05-28 |
| FI3870574T3 (fi) | 2023-04-03 |
| CA3115568A1 (en) | 2020-04-30 |
| PL3870574T3 (pl) | 2023-05-02 |
| IL282386B2 (en) | 2024-02-01 |
| IL282386B1 (en) | 2023-10-01 |
| CR20210265A (es) | 2021-08-24 |
| DK3870574T3 (da) | 2023-04-11 |
| BR112021005986A2 (pt) | 2021-06-29 |
| ZA202101788B (en) | 2024-09-25 |
| SG11202103823PA (en) | 2021-05-28 |
| HUE061652T2 (hu) | 2023-07-28 |
| CN112839938B (zh) | 2023-07-07 |
| IL282386A (en) | 2021-06-30 |
| CN112839938A (zh) | 2021-05-25 |
| JP2022512793A (ja) | 2022-02-07 |
| HRP20230328T1 (hr) | 2023-06-09 |
| AU2019367191B2 (en) | 2022-09-08 |
| US11987573B2 (en) | 2024-05-21 |
| WO2020083975A1 (en) | 2020-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282386A (en) | Aminopyrimidine/pyrazine history as CTPS1 inhibitors | |
| IL277455A (en) | History of aminopyrimidines as CTPS1 inhibitors | |
| EP3324977A4 (en) | BENZODIAZEPINE DERIVATIVES AS INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS (RSV) | |
| EP3719012A4 (en) | URACIL COMPOUND AS C-METH / AXL INHIBITOR | |
| EP3733671A4 (en) | AMINO-FLUOROPIPERIDINE DERIVATIVES USED AS A KINASE INHIBITOR | |
| IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
| EP3297437A4 (en) | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KINASES | |
| IL275207A (en) | An oxyfluoropiperidine derivative as a kinase inhibitor | |
| EP3564216A4 (en) | PYRIMIDINE DERIVATIVE | |
| ZA201808014B (en) | Adenine derivatives as protein kinase inhibitors | |
| EP3541806A4 (en) | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | |
| EP3372589A4 (en) | pyrimidine derivative | |
| IL269144A (en) | Pyrrolotriazine derivatives as kinase inhibitors | |
| EP3347357A4 (en) | HETEROCYCLIC KINASEINHIBITORS OF THE TEC FAMILY | |
| ZA201908372B (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors | |
| EP3618837A4 (en) | MULTI-DIRECTIONAL NUCLEOSIDE DERIVATIVES | |
| AU2017904208A0 (en) | Novel kinase inhibitors i |